D.N.C.B. for malignant melanoma: significance in the treatment strategy.
F. Truchetet(Hôpital Privé Marseille Beauregard), E Grosshans(Hôpitaux Universitaires de Strasbourg), Cécile Chartier(Io Therapeutics (United States)), Esther Heid, J Friedel
PubMed
April 12, 1990
Cited by 12
Related Papers
Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
|Journal of Virology|1996|651
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
|Proceedings of the National Academy of Sciences|2012|630
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
|PLoS ONE|2008|582
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
|Journal of Clinical Oncology|2021|431
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial
|European Journal of Cancer|2003|240